ACTA1 and renal fibrosis: We have shown that anti-OSM antibody increased the expression of E-cadherin and decreased the expression of α-SMA, suppressed the expression of MCP-1 and ICAM-1, attenuated renal fibrosis, and partially improved 24-hour urinary protein excretion and BUN production.